CBOE Holdings Inc.

06/18/2019 | Press release | Distributed by Public on 06/18/2019 05:05

AstraZeneca, Merck Report LYNPARZA Approved In EU For Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer

Cboe - Market News Story

AstraZeneca, Merck Report LYNPARZA Approved In EU For Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer

Benzinga Newsdesk 6/18/2019 5:31:06 AM